EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Liver-Enriched Long Non-Coding RNA FAM99A Suppresses Tumorigenesis Through Negative Regulation of Protein Synthesis

Nima Sarfaraz, Ranjit Kaur, Sky Harper, Lilly Oni, Srinivas Somarowthu, Michael J Bouchard

Journal of Molecular Biology · 2026

DOI: 10.1016/j.jmb.2026.169653 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Biology, 2026. Verfasst von Nima Sarfaraz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Molecular and Cell Biology and Genetics, Graduate School of Biomedical Sciences and Professional Studies, College of Medicine, Dr…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Liver Neoplasms, Protein Biosynthesis, Carcinogenesis. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pennsylvania Department of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer represents a significant global health burden, with limited therapeutic options for advanced disease. Long non-coding RNAs (lncRNAs) are increasingly found to play crucial roles in hepatic biology and disease progression. Here, we identify FAM99A as a highly liver-enriched lncRNA that is systematically downregulated across liver malignancies, with reduced expression correlating with poor clinical outcomes. FAM99A exhibits remarkable tissue specificity with minimal expression outside the liver, and its levels rapidly decline during primary hepatocyte dedifferentiation in culture. Through isoform analysis, we establish FAM99A-203 as the predominant transcript in normal liver tissue and observe altered isoform distribution in liver cancers. Functionally, FAM99A overexpression inhibits anchorage-independent growth in liver cancer cell lines. Transcriptomic analysis reveals that FAM99A negatively regulates translation-related pathways in both liver cancer cells and primary hepatocytes. This is corroborated by protein synthesis assays showing that FAM99A overexpression substantially reduces global translation rates. Targeted RNase H-mediated extraction coupled with mass spectrometry identifies multiple components of the translation machinery as direct FAM99A binding partners, including eukaryotic translation initiation factors and RNA helicases involved in ribosome biogenesis. Clinical data analysis demonstrates significant inverse correlations between FAM99A expression and ribosomal protein genes in liver cancer patients. Additionally, hepatitis B virus appears to downregulate FAM99A expression, potentially contributing to its oncogenic properties. Our findings establish FAM99A as a liver-enriched translational regulator that exerts tumor-suppressive effects by restraining protein synthesis rates, offering insights into hepatocarcinogenesis and the potential of FAM99A as both a biomarker and agent in new therapeutic avenues.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingLiver NeoplasmsProtein BiosynthesisCarcinogenesisHumansGene Expression Regulation, NeoplasticLiverHepatocytesCell Line, TumorAnimalsCarcinoma, Hepatocellular

Stichwörter der Autor:innen

FAM99ALncRNAhepatocellular carcinomaliver cancertranslation

Substanzen

RNA, Long Noncoding

Autor:innen und Institutionen

  • Graduate Program in Molecular and Cell Biology and Genetics, Graduate School of Biomedical Sciences and Professional Studies, College of Medicine, Drexel University, Philadelphia, PA, USA.
  • Baccalaureate Program in Chemistry, Department of Chemistry, Drexel University, Philadelphia, PA, USA.
  • Graduate Program in Biochemistry of Health and Disease, Graduate School of Biomedical Sciences and Professional Studies, College of Medicine, Drexel University, Philadelphia, PA, USA.
  • Department of Biochemistry and Molecular Biology, College of Medicine, Drexel University, Philadelphia, PA, USA. Electronic address: ss4473@drexel.edu.
  • Department of Biochemistry and Molecular Biology, College of Medicine, Drexel University, Philadelphia, PA, USA. Electronic address: boucharm@musc.edu.

Förderung

  • Pennsylvania Department of Health

Zitieren

APA

Sarfaraz, N., Kaur, R., Harper, S., Oni, L., Somarowthu, S., & Bouchard, M. J. (2026). The Liver-Enriched Long Non-Coding RNA FAM99A Suppresses Tumorigenesis Through Negative Regulation of Protein Synthesis. Journal of Molecular Biology. https://doi.org/10.1016/j.jmb.2026.169653

Vancouver

Sarfaraz N, Kaur R, Harper S, Oni L, Somarowthu S, Bouchard MJ. The Liver-Enriched Long Non-Coding RNA FAM99A Suppresses Tumorigenesis Through Negative Regulation of Protein Synthesis. Journal of Molecular Biology. 2026. doi:10.1016/j.jmb.2026.169653

BibTeX
@article{Sarfaraz2026,
  author = {Sarfaraz, Nima and Kaur, Ranjit and Harper, Sky and Oni, Lilly and Somarowthu, Srinivas and Bouchard, Michael J},
  title = {The Liver-Enriched Long Non-Coding RNA FAM99A Suppresses Tumorigenesis Through Negative Regulation of Protein Synthesis},
  journal = {Journal of Molecular Biology},
  year = {2026},
  doi = {10.1016/j.jmb.2026.169653}
}
Kostenlos starten →